Qube Research & Technologies (QRT)’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-51,210
Closed -$301K 5027
2023
Q4
$301K Buy
+51,210
New +$606K ﹤0.01% 2575
2023
Q1
Sell
-12,009
Closed -$1.65M 3151
2022
Q4
$1.65M Buy
+12,009
New +$4.07M 0.01% 1018
2022
Q2
Sell
-302
Closed -$191K 3275
2022
Q1
$191K Buy
302
+78
+35% +$49.2K ﹤0.01% 1954
2021
Q4
$200K Buy
+224
New +$235K ﹤0.01% 1974
2021
Q3
Sell
-474
Closed -$574K 2935
2021
Q2
$574K Buy
474
+217
+84% +$293K 0.01% 1216
2021
Q1
$341K Buy
257
+153
+147% +$217K 0.01% 1393
2020
Q4
$139K Buy
+104
New +$119K ﹤0.01% 1599

Other funds holding CANO

Qube Research & Technologies (QRT)'s CANO Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 51,210 shares — an estimated $301K sold.

Qube Research & Technologies (QRT) first reported a position in CANO in Q4 2020 and held it in 7 quarters. The position peaked at $1.65M in Q4 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 51,210 Cano Health, Inc. shares in Q1 2024, an estimated $301K.
  • Qube Research & Technologies (QRT) first reported a position in Cano Health, Inc. in Q4 2020 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Cano Health, Inc. position peaked at $1.65M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.